ID: MRFR/HC/7298-CR | February 2020 | Region: Global | 115 pages
Biological experimentation and drug origination are the two basic extents of cell culture. Handling the sterile solution is a cumbersome task and is very much prone to spoilage. This process of handling and transporting the solution to different containers can be made easy through automated cell culture systems. With the help of improved technology and automated cell culture equipment, the cultivation and preservation of cells and tissues in desired circumstances have become easier. An automated cell culture system guarantees uniformity in the process. The process becomes more cost-effective and less time-consuming. Through this system, a lab technician can also monitor and record developments easily.
It is expected that the automated cell culture equipment market share will grow with a CAGR of 12.04%. It is expected to reach USD 4,906.53 Million by the end of 2025.
Researchers from across the globe are working on developing a vaccine or an antidote for the coronavirus. The strains of SARS-Cov-2 are obtained from a patient’s body and then the researchers work on the automated cell culture system to extract the primary and stem cell lines from the samples obtained. This sudden surge in the field of pharmaceuticals and its related Research & Development has increased the automated cell culture equipment market share. This equipment is needed for rapid testing and trial of coronavirus.
Automated Cell Culture Equipment Market Revenue, by lab automation type, 2018 (% share)
Sources: MRFR Analysis
The widespread presence of chronic diseases such as cancer, HIV, Tuberculosis, calls for the requirement of new and useful drugs. In a report, the National Cancer Institute indicated that the estimated number of cases of cancer diagnosed and reported in the US in 2018 was 1,735,350. The numbers are sloping upwards in every part of the world. This will increase the automated cell culture equipment market share.
The hike in the number of tests being done regularly due to the prevalent infectious diseases leads to the increased demand for testing and research equipment. As the automated cell, culture systems are time and cost-effective, the results can be drawn instantly. This has increased automated cell culture equipment market size.
The environment is dynamic as changes are occurring in the blink of an eye. There is a dearth of skilled workers who can operate the instruments and machines. Automated cell culture systems can prove to be cost-effective in the long run but their maintenance is a costly affair.
Value Chain Analysis
Automated cell culture equipment reduces all the redundant activities on part of the workers. It has decreased manual labor. It also ensures uniformity and consistency in managing the material. It, thus, ensures the quality of the research and the material. The efficiency is also increased as several people can work on the same samples but the outcomes will not fluctuate.
Automated Cell Culture Equipment Market Share, by Region, 2018 (%)
Sources: MRFR Analysis
Automated cell culture equipment market share can be classified into various segments. These are: based on lab automation type, based on product type, based on application, and based on end-user.
Based on lab automation type:
It can be further subdivided into two types, namely, modular automation and whole lab automation. The modular automation is anticipated to capture the largest market share of 67.20% by the end of the year 2025. It is helpful in pre-clinical trials as well as in-depth research. Whole lab automation helps in sample arrangements as well as screening.
Based on product type:
An automated cell culture system provides three types of products, namely, consumables, equipment, and software. The software runs through the computer system and enables the lab technicians to give commands and gets desired results. Consumables are the products that need constant supplies as they are to be replaced with every use. Equipment is necessary to carry on the research process.
Based on application:
Automated cell culture equipment can be easily applied to different fields such as biopharmaceutical productions, vaccine production, tissue engineering, stem cell therapy, and toxicity testing, general diagnosis, drug screening and development, and others.
Based on end-user:
Pharmaceutical and biotechnological industries, hospitals and diagnostic labs, pathological labs, research, and academic institutes comprise automated cell culture equipment market size. This equipment is required in the labs for regular testing, maintaining records as well as monitoring the results.
The automated cell culture equipment market is leaving its impression in every corner of the world. The regions include America, Europe, Asia-pacific, Middle-East, and Africa.
The market share in America can be divided into North America, which can further be divided in the US and Canada, and Latin America. America, having a large population, robust healthcare infrastructure, and due to the increase in Research & Development, is the greatest consumer of automated cell culture equipment. America alone had a market share of 42.54% in the year 2018. It is expected that this share will increase double folds in the coming years
The European market can be further segmented into Western Europe, which has further branches in Germany, France, Italy, UK, Spain, and Eastern Europe. Europe is the second-largest customer of automated cell culture equipment.
In Asia-pacific regions, the branches can be seen in the areas such as China, India, Japan, South Korea, and Australia. It holds the third-largest position in the automated cell culture equipment market share. It is also estimated to grow tremendously throughout the forecast.
The Middle East and Africa are growing at a slower pace but will provide a promising market in the coming future. This is because there are many developing nations in this region.
The list of major key players involved in the automated cell culture equipment market research is as follows:
The above-listed companies work on the screening and development of new as well as useful drugs. They invest in the latest technologies to perform the tasks more effectively and efficiently. Automated cell culture systems provide them with equipment that increases the feasibility of their processes and thus, gives durable outcomes.
Various developments are seen in the automated cell culture equipment market which is as follows:
This market research report of automated cell culture equipment market includes the following elements:
This automated cell culture equipment market research report enumerates how the cell culture system works. The automation of the cell culture system will give certain benefits to the companies. It will lead to more accuracy in the functioning; it will reduce the cost and time, and it will lower the chances of inaccuracy and miscalculations. The widespread presence of chronic diseases such as cancer, HIV, Tuberculosis, calls for the requirement of new and useful drugs. It becomes the major driving force of the automated cell culture equipment market. It has decreased the manual labor and redundant activities by the workers.
|Market Size||USD 4,906.53 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Lab Automation Type, Product Type, Application and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Tecan Trading AG, Hamilton Company, Beckman Coulter, Inc., Pfizer Inc., Hitachi, Ltd, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Anton Paar GmBH, Sartorius AG, Perkinelmer, Inc., and Siemens|
|Key Market Opportunities||Growing research & development (R&D) initiatives in the pharmaceutical industry|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Automated cell culture equipment market is touted to record a substantial market valuation of USD 4.9 billion by 2025.
Automated cell culture equipment market is projected to register a moderate 12.04% CAGR in the forecast period.
The massive growth of the automated cell culture equipment market is driven by the growing R&D projects in the pharmaceutical industry.
The modular automation segment is expected to observe substantial demand over the review period.
The APAC is poised to secure the highest CAGR.
The stem cell therapy segment is slated to mature as the fastest-growing segment.
A few eminent market players functioning in the global automated cell culture equipment market are Siemens, Pfizer Inc., Thermo Fisher Scientific Inc., Hitachi, Ltd, among others.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.